{"id":82131,"date":"2026-06-12T06:06:34","date_gmt":"2026-06-12T06:06:34","guid":{"rendered":"https:\/\/www.europesays.com\/ch\/82131\/"},"modified":"2026-06-12T06:06:34","modified_gmt":"2026-06-12T06:06:34","slug":"roche-backs-full-year-view-as-quarterly-sales-rise","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/ch\/82131\/","title":{"rendered":"Roche Backs Full-Year View as Quarterly Sales Rise"},"content":{"rendered":"<p data-type=\"paragraph\" data=\"[object Object]\" class=\"css-1qg6i2u eew040j0\"><a data-type=\"company\" href=\"https:\/\/www.wsj.com\/market-data\/quotes\/CH\/XSWX\/ROP\" target=\"_blank\" class=\"ekxajjj0 css-i0lbhy-OverridedLink\" rel=\"nofollow noopener\">Roche<\/a> <a color=\"var(--color-inkSubtle)\" href=\"https:\/\/www.wsj.com\/market-data\/quotes\/CH\/XSWX\/ROP\" class=\"css-1fr2kw9-ChicletStyle e1vl9ktx2\" rel=\"nofollow noopener\" target=\"_blank\">ROP 2.63%increase; up pointing triangle<\/a> confirmed its full-year guidance after reporting a first-quarter rise in sales driven by high demand for its innovative medicines and diagnostics.<\/p>\n<p data-type=\"paragraph\" data=\"[object Object]\" class=\"css-1qg6i2u eew040j0\">The Swiss pharmaceutical giant said Thursday that sales rose 6% at constant currency to 14.72 billion Swiss francs ($18.76 billion) for the first three months of the year. Analysts were expecting group sales of 14.73 billion francs, according to a Visible Alpha consensus.<\/p>\n<p class=\"css-16aepit e1jdulti0\">Copyright \u00a92026 Dow Jones &amp; Company, Inc. All Rights Reserved. 87990cbe856818d5eddac44c7b1cdeb8<\/p>\n","protected":false},"excerpt":{"rendered":"Roche ROP 2.63%increase; up pointing triangle confirmed its full-year guidance after reporting a first-quarter rise in sales driven&hellip;\n","protected":false},"author":2,"featured_media":82132,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":"","_share_on_mastodon":"0"},"categories":[124],"tags":[6277,12822,34156,6274,1126,6273,230,197,6275,834,16097,4128,25348,6288,1831,42329,228,6263,337,134,994,34155,17723,17,6278,6267,6279],"class_list":["post-82131","post","type-post","status-publish","format-standard","has-post-thumbnail","category-roche","tag-ce-industry-news-filter","tag-cancer-drugs","tag-chrop","tag-content-types","tag-corporate","tag-corporate-industrial-news","tag-earnings","tag-europe","tag-factiva-filters","tag-financial-performance","tag-gcapi","tag-healthcare","tag-healthcare-life-sciences","tag-industrial-news","tag-life-sciences","tag-linkendrnrealtime-linkedarticle-dnco20260423002425","tag-manufacturing","tag-newsplus","tag-pharmaceuticals","tag-roche","tag-roche-holding","tag-rop-eb","tag-sales-figures","tag-switzerland","tag-synd","tag-western-europe","tag-wsj-pro-wsj-com"],"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@ch\/116735638368730731","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/posts\/82131","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/comments?post=82131"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/posts\/82131\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/media\/82132"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/media?parent=82131"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/categories?post=82131"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/tags?post=82131"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}